How to Compare Online GLP-1 Providers: 10 Questions to Ask Before Joining

An online weight-loss clinic may advertise semaglutide for $99, tirzepatide for $199, or “GLP-1 treatment” for less than the cost of a traditional specialist visit. But that first number rarely tells you everything you need to know.

One price may cover medication but little ongoing care. Another may be only a membership fee, with the prescription charged separately. A third may be an introductory price that increases after the first month or as the dosage changes. Two programs that appear similar may also be offering fundamentally different products: one may help patients obtain an FDA-approved medication, while the other supplies a compounded preparation that has not gone through FDA premarket review.

The quality of the medical relationship can differ just as much. Depending on the platform, you may have a video appointment with an identifiable clinician, an asynchronous questionnaire reviewed later, regular follow-ups, or mainly customer-service messaging after the prescription is issued.

That does not mean online treatment is inherently inferior. Telehealth can make care faster and more accessible, and it allows patients to communicate with clinicians through video, telephone, secure messaging, and remote monitoring. It may not, however, be suitable for every person or every medical situation.

The goal is therefore not to locate the flashiest offer. It is to understand exactly what the provider is offering—and what will happen after you enter your payment information.

CliniqGuide does not provide medical care or determine whether a medication is appropriate for you. Prescription treatment requires an evaluation by a qualified, licensed healthcare professional.

Key takeaways

Compare the complete program, not the introductory price. Membership, medication, laboratory work, shipping, higher doses and insurance-related expenses may be billed separately.
Confirm the exact product. An FDA-approved brand-name medication and a compounded preparation containing semaglutide or tirzepatide are not interchangeable regulatory categories.
Ask who is responsible for your medical care. You should be able to identify the clinician or affiliated medical practice and verify that the prescriber can legally treat patients in your state.
Do not accept vague pharmacy language. Ask for the dispensing pharmacy’s name and verify its license through the relevant state board of pharmacy.
Follow-up care matters. A good program should explain how dosage decisions are made, how side effects are handled and how quickly a clinician can be reached.
Read the cancellation policy before paying. Prescription sales are often final, and some memberships renew unless they are canceled a specific number of hours or days before the next billing date.

What does an online GLP-1 provider actually provide?

An online GLP-1 company is usually not a single entity performing every part of treatment. The consumer-facing platform may provide technology, scheduling, payment processing and customer service. Medical evaluation may be performed by clinicians working through an affiliated professional practice. A separate pharmacy may dispense and ship the medication.

In practical terms, you may be entering several connected relationships:

A subscription or service agreement with the telehealth platform
A clinical relationship with a physician, nurse practitioner or physician assistant
A prescription relationship with a pharmacy
In some programs, a separate arrangement involving laboratory testing, coaching or nutrition services

This structure is not automatically concerning. It is common in telehealth. The problem arises when a website makes it difficult to tell who is delivering the medical care, who is dispensing the drug or whom to contact when something goes wrong.

Licensing also depends partly on where the patient is physically located. States regulate cross-border telehealth differently, and providers may need a full state license, temporary authority, compact eligibility or telehealth registration to treat a patient in another state. HHS guidance advises providers to verify the patient’s location before the appointment.

How the online enrollment process usually works

Although procedures vary, most online programs follow a version of this sequence:

You complete an intake questionnaire. This may ask about your height, weight, medications, allergies, health conditions, pregnancy plans and previous treatment.
A clinician reviews the information. Some programs schedule a live video appointment. Others use asynchronous review and request additional information when needed.
The clinician determines whether treatment is appropriate. Completing the intake does not guarantee a prescription.
The program discusses medication options. The available choices may include FDA-approved products, compounded preparations or non-GLP-1 medications.
Insurance authorization may be attempted. For branded medication, the provider may submit a prior authorization or help document eligibility.
A prescription is sent to a pharmacy. Medication may be shipped or picked up locally.
Treatment begins at a clinician-selected dose. Many medications use gradual dose escalation to improve tolerability.
Follow-up occurs. The clinician may assess side effects, adherence, weight trends, other health measurements and whether dosage changes are appropriate.

The meaningful differences are found inside those steps. How much time does the clinician spend reviewing your history? Are visits performed by video? Is laboratory work ordered when clinically appropriate? Can you reach the prescriber between appointments? Those details are more revealing than a promise to “get started in minutes.”

The 10 questions to ask before joining an online GLP-1 program

Who will evaluate me and remain responsible for my care?Do not stop at a statement such as “doctor-led” or “clinician-supported.” Ask for specifics.

What type of clinician will review my case?
Will I know the clinician’s full name and credentials?
Is the clinician licensed or otherwise legally authorized to treat me in the state where I am located?
Will I see the same clinician during follow-ups?
Is my visit conducted by video, telephone or questionnaire?
Can I verify the clinician through my state’s professional-license database?

A nurse practitioner or physician assistant can appropriately prescribe in many settings when acting within applicable state law and professional scope. The issue is not whether every patient sees a physician. The issue is whether the provider’s identity, qualifications, licensing and clinical responsibility are transparent.

A program should also distinguish the medical practice from the consumer brand. For example, MEDVi states that medical treatment is provided through affiliated professional entities, while Mochi explains that its corporate platform provides administrative and technology services and that professional medical services come from affiliated practices.

Positive signal: The company identifies its medical entities and lets you verify the treating clinician.

Warning sign: The site refers only to a generic “medical team,” will not identify the prescriber or cannot explain who handles medical questions after the prescription is issued.

2. What medication am I actually being offered?

“Semaglutide” is not a sufficiently complete answer.

Ask whether the proposed treatment is:

An FDA-approved medication in its original manufacturer packaging
An FDA-approved drug being prescribed for an off-label use
A patient-specific compounded preparation
A product mixed with another ingredient
An injectable or oral formulation
A vial, syringe, pen or tablet
A treatment that changes depending on availability or insurance

Wegovy contains semaglutide and is FDA approved for specific weight-management indications. Zepbound contains tirzepatide, which acts at both GIP and GLP-1 receptors, and is approved for long-term weight reduction in qualifying adults as well as certain adults with obesity and obstructive sleep apnea. Ozempic and Mounjaro are approved primarily for type 2 diabetes, although clinicians sometimes prescribe medications off label when they judge it medically appropriate.

A compounded preparation is different. FDA does not approve the finished compounded product before marketing and does not verify it in the same manner for safety, effectiveness and manufacturing quality. FDA currently advises that compounded drugs should be used when a patient’s medical needs cannot be met by an FDA-approved drug.

Compounded medication may still be prescribed in particular patient-specific circumstances, but the provider should not describe it as FDA approved, a generic version of an approved GLP-1 or automatically equivalent to a branded product. In 2026, FDA announced additional action against misleading mass marketing of non-FDA-approved compounded GLP-1 products.

FDA-approved and compounded GLP-1 products are not the same category

Question	FDA-approved medication	Compounded preparation
Has the finished product undergone FDA premarket review?	Yes	No
Is it supplied in manufacturer packaging?	Normally yes	No; prepared and labeled by the dispensing pharmacy
Is it automatically a generic version of the branded drug?	Not applicable	No
Can the provider claim it is FDA approved?	Yes, when accurately referring to the approved product and indication	No
Should the pharmacy be identified?	Yes	Yes—particularly important for a compounded product
May availability or legality change with regulatory policy?	Supply and coverage can change	Compounding availability is especially dependent on federal and state requirements

The choice between approved and compounded medication should be discussed with a licensed clinician, not reduced to a price comparison.

3. Which pharmacy will fill the prescription?

A telehealth platform is not necessarily the dispensing pharmacy. Ask:

What is the pharmacy’s legal name?
In which state is it located?
Is it licensed to dispense to patients in my state?
Will the pharmacy name and telephone number appear on my prescription label?
Can I speak with a pharmacist?
Does the provider use more than one pharmacy?
Could my pharmacy or formulation change between refills?
For a compounded drug, is it prepared under section 503A, section 503B or another applicable pathway?

FDA recommends checking the pharmacy through the appropriate state board of pharmacy. It advises against using an online pharmacy that is not listed and says a legitimate online pharmacy should require a prescription, provide a U.S. physical address and telephone number, and have a licensed pharmacist available.

Do not assume that “FDA registered” means FDA approved or that it guarantees the quality of every finished compounded preparation. Registration, inspection history, state licensing, accreditation and FDA approval are separate concepts.

Some providers identify at least part of their pharmacy network publicly. MEDVi, for example, currently names Triad Rx as a partner pharmacy. Mochi refers publicly to a pharmacy network but does not identify a single universal pharmacy on its general contact page, which may reflect the use of different pharmacies depending on the medication and patient location.

The pharmacy that would fill your prescription is what matters. Ask before the medication is ordered.

4. What does the medical evaluation include?

A provider should collect enough information to determine whether remote treatment is appropriate and whether additional evaluation is needed.

A responsible assessment may address:

Current weight and relevant weight history
Height and BMI as one screening measure
Medical and surgical history
Current prescriptions, supplements and allergies
Diabetes and blood-sugar treatment
Previous pancreatitis or gallbladder problems
Digestive symptoms or delayed stomach emptying
Personal or family history relevant to thyroid cancer warnings
Kidney problems and dehydration risk
Pregnancy, breastfeeding and pregnancy plans
Planned procedures involving anesthesia or deep sedation
Eating-disorder history or other circumstances affecting suitability
Baseline laboratory testing when clinically indicated

Not every patient requires the same laboratory panel. A program that orders no tests for anyone is not necessarily more convenient, and a program that sells every applicant an extensive lab package is not necessarily more thorough. The clinician should be able to explain why a test is or is not needed in your situation.

The evaluation should also allow you to ask questions. A questionnaire can be useful for gathering history, but it should not become a way to avoid meaningful clinical judgment.

Ask directly: “What happens if my intake suggests that telehealth treatment is not appropriate?” A credible answer may involve requesting records, ordering testing, referring you for an in-person examination or declining to prescribe.

5. What will I realistically pay after the introductory offer ends?

To compare prices accurately, calculate at least the first three months and, ideally, the first year.

Ask for each of these costs separately:

Initial medical evaluation
Recurring membership
Medication
Dose increases
Shipping and temperature-controlled delivery
Supplies such as syringes or alcohol pads
Laboratory work
Insurance-administration or prior-authorization services
Nutrition or coaching services
Replacement shipments
Required multi-month prepayment
Cancellation fees or nonrefundable charges

Examples of different pricing models

The table below is not a ranking. It illustrates how current advertised prices can represent different things. Prices and offers were reviewed July 23, 2026 and can change at any time.

Provider	What the prominent price represents	Medication included?	Important qualification
Ro	$39 first month; then $149 monthly, or as low as $74 per month with annual prepayment	No	Medication is billed separately. Ro advertises insurance support and cash-pay access to FDA-approved products. (Ro)
Mochi Health	$39 promotional first month; then $79 monthly membership	No	Its site currently advertises compounded semaglutide starting at $99 and compounded tirzepatide starting at $199 in addition to branded options. Medication and diagnostic services are separate from membership. (Mochi Health)
TrimRx	Current landing-page prices advertise a GLP-1 program at $179 and a GLP-1/GIP program at $279	Yes, according to the current offer	The company advertises an all-in-one price without a separate membership fee; verify the precise medication, dose pricing and pharmacy at checkout. (TrimRX)
MEDVi	Its semaglutide landing page advertises a starting first-month price; current search presentation shows $179	Yes, according to the provider	MEDVi states that physician review, guidance, shipping and medication are included. Confirm the ongoing refill price because the publicly rendered page does not consistently display the dynamic amount. (MEDVi)

These models are not directly interchangeable.

For example, Mochi’s currently advertised starting compounded semaglutide price plus its ongoing monthly membership would produce a starting component cost of approximately $178 per month after the introductory membership period, before any separately billed diagnostics or other services. Ro’s membership may cost more before medication, but it follows a different model focused on FDA-approved options, insurance assistance and separately priced prescriptions.

Neither number tells you which program is clinically appropriate or less expensive for you. Insurance coverage, medication choice, dose, treatment duration and eligibility can reverse the apparent price difference.

A better pricing question

Instead of asking, “What does it start at?” ask:

“Assuming I remain enrolled for six months and follow the clinician’s normal dosing plan, what could I pay for membership, medication, shipping, laboratory work and follow-up combined?”

Ask the provider to answer in writing.

6. What help will I receive with insurance—and what happens if coverage is denied?

“Insurance accepted” can mean several different things:

The clinic bills insurance for medical visits
The pharmacy bills insurance for the medication
The clinic helps submit a prior authorization
The clinic checks your benefits but does not guarantee approval
Only branded medications are processed through insurance
The membership remains cash pay even when the drug is covered
The program offers cash-pay alternatives after denial

Ro says its membership includes an insurance concierge, but the medication is still separate from the membership fee. Mochi states that its team may contact the insurer and assist with documentation when a branded medication is on the patient’s formulary.

Before enrolling, ask:

Will you verify whether my plan covers obesity medication?
Do you submit the prior authorization?
Do you handle appeals?
Is prior-authorization support included in the membership?
Will I continue paying the membership while waiting?
What happens if the insurer denies treatment?
Can I decline a compounded alternative without losing the membership fee?
Can I fill an approved prescription at my own local pharmacy?

No provider can guarantee insurance approval. Your plan, employer benefits, formulary, clinical criteria, deductible and authorization requirements can all affect the outcome.

7. What follow-up care is included after I receive the medication?

The first prescription should not be the end of the medical relationship.

Ask how the program handles:

Side-effect questions
Dose adjustments
Refill approval
Missed doses
Weight or blood-sugar changes
Other medication changes
New symptoms or diagnoses
Pregnancy
Planned surgery or sedation
Loss of insurance coverage
Medication shortages
Stopping treatment

Find out whether “unlimited support” means access to a clinician or mainly to a customer-care team. Both can be useful, but they serve different purposes.

Ask for practical response times:

How soon can I message my prescriber?
Is clinical support available at night or on weekends?
Can I schedule an urgent telehealth visit?
What issues are handled by a pharmacist?
What symptoms require urgent in-person care instead?

Mochi currently advertises physician and care-team access, in-app coaching and 24/7 care-team support. Ro describes ongoing provider messaging, check-ins, coaching and laboratory testing when needed. These are provider-reported service descriptions; the reader should still verify appointment availability and the distinction between clinical and administrative support.

8. How are dosing, side effects and treatment interruptions handled?

GLP-1-related medications are generally not a “set it and forget it” prescription. Dosing is individualized, and escalation may be delayed when tolerability is a concern.

Current Wegovy labeling uses gradual dose escalation for both injectable and oral formulations. Zepbound labeling similarly begins with a lower starting dose and increases in steps, with the eventual maintenance dose selected according to response and tolerability.

Ask the provider:

Does the monthly price increase as my dose increases?
Who decides when the dose changes?
Can escalation be delayed?
What happens if I cannot tolerate a higher dose?
Will I be charged for medication that cannot be used?
What happens after several missed doses?
Can the provider coordinate with my primary-care clinician?
How are changes documented and communicated to the pharmacy?

Be cautious when marketing treats a higher dose as an automatic goal or implies that dose increases guarantee better results. The appropriate maintenance dose depends on the drug, indication, response and tolerability.

Continuity also matters. A shipment delay is more than a customer-service inconvenience if it leads to missed doses or requires the clinician to reconsider how treatment is restarted.

9. What happens if I am not eligible—or if the medication becomes unavailable?

Before paying, ask what happens in each of these scenarios:

The clinician determines that medication is not appropriate
The requested drug is not prescribed
Insurance refuses coverage
The pharmacy cannot ship to your state
The medication is unavailable
You need an in-person evaluation
You experience side effects and stop early
You move or travel to another state
The provider changes its pharmacy or formulation
Federal or state compounding rules change

This is especially relevant for compounded GLP-1 programs. FDA determined that the national shortages of tirzepatide injection and semaglutide injection were resolved and ended the broad shortage-related enforcement periods that had permitted more extensive compounding of copies. In 2026, the agency also announced enforcement and policy actions targeting mass-marketed non-approved GLP-1 products.

That does not mean every patient-specific compounded prescription is automatically unlawful. It does mean that providers should be able to explain the current basis on which the pharmacy is preparing the drug and why the compounded preparation is being prescribed for the individual patient.

A vague answer such as “Compounded GLP-1s are always available” should not be treated as sufficient.

10. What are the cancellation, refund and privacy terms?

Medical subscriptions can involve two recurring charges: the care membership and the medication order. Canceling one may not automatically cancel the other.

Review:

How far before renewal you must cancel
Whether cancellation can be completed online
Whether email or telephone notice is required
Whether the membership fee is refundable
When a prescription becomes nonrefundable
Whether prepaid plans receive prorated refunds
Whether unused membership months are refundable
Whether cancellation ends access to the clinician immediately
Whether records can be transferred to another provider
What happens to your health and payment data

Current policies illustrate the differences:

Ro states that its Body membership automatically renews, previously paid membership fees are nonrefundable and cancellation should be completed at least 48 hours before renewal.
MEDVi requests cancellation at least 72 hours before the next billing date. Its policy provides limited refund circumstances, including certain early cancellations before services are received and clinical disqualification.
TrimRx states that processed subscription charges are generally nonrefundable and that prescription orders cannot be canceled after approval.
Mochi states that prescription medication sales are final and cannot be returned or refunded.

Take a screenshot of the offer and terms you accept. Save cancellation confirmations and note the next billing date.

Do not assume every health platform is protected in exactly the same way

Medical practices and pharmacies may be subject to HIPAA, but not every function of every wellness website or health app is necessarily covered in the same manner. The FTC has warned telehealth companies and health systems about tracking technologies that can disclose sensitive information and notes that non-HIPAA-covered companies still have obligations to protect health data.

Review the privacy policy for:

Advertising and analytics tracking
Sharing with affiliated medical practices and pharmacies
Use of deidentified or aggregated data
Communication by text or email
Data deletion requests
State-specific privacy rights
Whether information may be used for marketing

Trust signals and red flags

Positive trust signal	Potential warning sign
Identifies the treating medical practice and clinician	Will not identify who reviews the intake
Requires a prescription after medical evaluation	Promises medication before reviewing medical history
Names the dispensing pharmacy before ordering	Uses vague phrases such as “partner pharmacy” without identifying yours
Clearly labels medication as approved, off label or compounded	Calls a compounded drug FDA approved, generic or identical to the approved product
Provides itemized ongoing pricing	Displays only an introductory price
Explains how dosage affects cost	Avoids answering whether higher doses cost more
Provides clinician follow-up	Offers only sales or customer-service support
Publishes cancellation and refund terms	Makes cancellation difficult to locate or understand
Provides a U.S. address and working support channels	Lacks verifiable contact information
Ships medication with a prescription label and instructions	Sells unlabeled vials or “research use only” peptides for human treatment

FDA specifically identifies several telehealth warning signs: claims that a compounded product is the same as an FDA-approved drug, prices that appear too good to be true, damaged or inadequate packaging, no licensed-doctor screening and no clinician available to answer questions after the medication arrives.

“Research use only” products are not a legitimate substitute for prescription medication intended for human use.

Safety and eligibility questions to discuss with a clinician

Semaglutide and tirzepatide can be appropriate for some patients, but they are not suitable for everyone.

Current Wegovy and Zepbound labeling includes contraindications for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, as well as people with certain serious hypersensitivity reactions. Both labels include warnings involving gastrointestinal reactions, pancreatitis, gallbladder disease, kidney injury related to dehydration, hypoglycemia in certain circumstances and considerations surrounding anesthesia or deep sedation.

Common adverse reactions are frequently gastrointestinal. Depending on the medication, these may include nausea, diarrhea, vomiting, constipation and abdominal discomfort. The possibility and frequency vary by medication, dose and patient.

Patients should tell the prescribing clinician about all medications and relevant medical conditions. Pregnancy or plans to become pregnant are particularly important. Current labeling advises discontinuing Wegovy or Zepbound when pregnancy is recognized; Wegovy labeling also advises discontinuing semaglutide at least two months before a planned pregnancy because of its long half-life. Tirzepatide can affect absorption of oral medications and its label contains specific contraceptive guidance during initiation and dose escalation.

Seek prompt medical guidance for severe or persistent symptoms. Severe abdominal pain, repeated vomiting, inability to keep fluids down, signs of a serious allergic reaction or symptoms suggesting significant dehydration should not be handled solely through routine customer-service messaging. The medication labels advise discontinuation and clinical evaluation when pancreatitis is suspected and prompt medical attention for serious hypersensitivity reactions.

This is not a complete safety review. The prescriber and pharmacist should provide medication-specific counseling based on the exact product selected.

Who may appreciate an online GLP-1 program?

Online treatment may appeal to people who:

Have difficulty accessing an in-person obesity-medicine clinician
Prefer remote appointments and home delivery
Are comfortable using an app or secure portal
Can accurately provide their medical history
Want assistance with insurance authorization
Value recurring clinician or dietitian support
Understand that treatment may require long-term follow-up

It may be less suitable for people who:

Need an immediate physical examination
Have complex or unstable medical conditions requiring close in-person management
Cannot obtain necessary laboratory work or monitoring
Are uncomfortable administering or storing injectable medication
Need coordinated care across several specialists
Are seeking medication without a medical evaluation
Cannot reliably afford the ongoing cost
Are purchasing solely because of an introductory offer

A strong telehealth provider should recognize when remote care is insufficient and help direct the patient toward appropriate in-person evaluation.

A final checklist before entering your payment information

Ask the provider to answer these questions in writing:

Who will review my history, and can I verify that clinician’s license?
Will I have a live appointment or only an asynchronous review?
What exact drug, brand, formulation and route are being considered?
Is the product FDA approved, prescribed off label or compounded?
Which pharmacy will fill my prescription?
Can I verify that pharmacy through my state board?
What will I pay during months one, two and three?
Does the cost change by dose?
Are membership, medication, labs and shipping separate?
What happens if I am not prescribed the medication I requested?
What insurance and prior-authorization services are included?
How do I contact a clinician about side effects?
How often are follow-up appointments available?
What happens after missed doses or a delayed shipment?
How and when must I cancel?
Which payments become nonrefundable?
How is my health information used or shared?
Can my records and treatment plan be transferred if I leave?

A trustworthy provider should not be irritated by these questions. Clear answers are part of informed consent and responsible consumer service.

The bottom line

The right online GLP-1 provider is not simply the one with the lowest first-month price. It is the one whose care model, medication source, pharmacy, follow-up process, total cost and contractual terms are understandable before you enroll.

For one person, the better fit may be a program that helps secure insurance coverage for an FDA-approved drug. Another may value frequent clinician and dietitian access. Someone with a specific medical need may discuss a patient-specific compounded preparation with a licensed professional. Others may be better served by an in-person clinician who can perform an examination and coordinate more complex care.

The most useful comparison is therefore not provider versus provider in the abstract. It is each provider measured against the same set of questions—and against your medical, financial and practical needs.

Frequently asked questions

How can I tell whether an online GLP-1 provider is legitimate?

Start by identifying three parties: the treating clinician or medical practice, the telehealth company and the dispensing pharmacy. Verify the clinician through the applicable state professional board and the pharmacy through the state board of pharmacy. A legitimate service should require a medical evaluation and prescription, provide working contact information and offer access to clinical or pharmacy support. FDA advises against pharmacies that do not require prescriptions, are not properly licensed or lack a U.S. address and licensed pharmacist.

Legitimacy does not guarantee that a program is the right fit. You should still assess the depth of care, total cost, privacy policy and cancellation terms.

Is the cheapest online GLP-1 provider usually the best value?

Not necessarily. A low price may be an introductory rate, medication-only price or membership-only price. It may apply only to the lowest dose or require a multi-month commitment. A program with a higher visible price may include insurance assistance, laboratory work, clinician visits or coaching that another program bills separately.

Compare the estimated six- or 12-month total rather than the first charge. Also consider whether you can reach a clinician, whether the pharmacy is transparent and whether treatment can continue if the medication or your insurance coverage changes.

Is compounded semaglutide the same as Wegovy or Ozempic?

No. Wegovy and Ozempic are specific FDA-approved products manufactured by Novo Nordisk for different approved indications. A compounded semaglutide preparation is made by a compounding pharmacy for a prescription and is not an FDA-approved finished product.

FDA has warned companies not to market compounded GLP-1 preparations as generic, identical to or the same as FDA-approved drugs. The agency also states that unapproved versions do not undergo its premarket review for safety, effectiveness and quality.

Should an online GLP-1 provider require laboratory testing?

There is no single universal laboratory panel appropriate for every patient. The need for testing depends on medical history, current medications, symptoms, the proposed treatment and what recent records are available.

The provider should explain its approach. Some people may need baseline or follow-up testing, while others may have recent results that are sufficient. A provider should also be willing to refer a patient for an in-person assessment when remote information is not adequate.

Does completing an online intake guarantee that I will receive a prescription?

No. The intake provides information for a licensed clinician to evaluate. The clinician may prescribe a different medication, request more information, order testing, recommend in-person care or determine that prescription treatment is not appropriate.

A promise of a guaranteed prescription before medical review is a warning sign. FDA lists the absence of licensed-doctor screening and prescription requirements among the red flags for telehealth medication sellers.

Will insurance cover an online GLP-1 program?

Coverage depends on both the medical service and the medication. A plan may cover the medication while excluding the provider’s membership fee. It may cover diabetes indications but apply different requirements to obesity treatment. Prior authorization, BMI criteria, weight-related conditions, step therapy and employer-selected exclusions may affect coverage.

Ask the provider whether it checks benefits, submits authorizations, assists with appeals and continues charging membership fees while the insurance decision is pending. No telehealth company can guarantee that your insurer will approve a drug.

Can an online provider increase my GLP-1 dose automatically?

Dose changes should be authorized by the treating clinician and based on the medication’s instructions, your response and tolerability. Both Wegovy and Zepbound use escalation schedules, but labeling allows clinical judgment regarding tolerability and maintenance dosing.

Ask who reviews each refill and what happens if you are experiencing side effects. Do not change the dose on your own unless your prescriber has specifically instructed you to do so.

What happens when I cancel a GLP-1 membership?

Cancellation terms vary. Ending the membership may stop future clinical services but may not reverse a medication order that has already been approved or processed. Membership fees and prescription sales are often nonrefundable. Some companies also require cancellation 48 or 72 hours before renewal.

Before canceling treatment, discuss continuity with a qualified clinician. Ask for your records, current dose, medication history and a transition plan if another provider will assume care.

Sources

FDA prescribing information for Wegovy, revised May 2026.
FDA prescribing information for Zepbound, revised February 2026.
FDA guidance on unapproved GLP-1 products and telehealth red flags.
FDA policy updates following resolution of the semaglutide and tirzepatide shortages.
FDA 2026 enforcement statement concerning mass-marketed non-approved GLP-1 products.
FDA proposal concerning semaglutide, tirzepatide and liraglutide on the 503B bulks list.
FDA BeSafeRx pharmacy-verification guidance.
HHS cross-state telehealth licensing guidance. FTC and HHS health-data privacy and tracking guidance.
Ro weight-loss pricing and terms.
Mochi Health homepage, pricing, services and refund policy.
MEDVi program, pharmacy and cancellation disclosures.
TrimRx pricing, terms and shipping policy.